Structure Therapeutics Statistics
Total Valuation
GPCR has a market cap or net worth of $2.14 billion. The enterprise value is $1.70 billion.
| Market Cap | 2.14B |
| Enterprise Value | 1.70B |
Important Dates
The next estimated earnings date is Wednesday, August 14, 2024, after market close.
| Earnings Date | Aug 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
GPCR has 57.05 million shares outstanding. The number of shares has increased by 94.98% in one year.
| Shares Outstanding | 57.05M |
| Shares Change (YoY) | +94.98% |
| Shares Change (QoQ) | +26.78% |
| Owned by Insiders (%) | 4.56% |
| Owned by Institutions (%) | 81.33% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 4.97 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.05, with a Debt / Equity ratio of 0.01.
| Current Ratio | 19.05 |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -30.30% and return on invested capital (ROIC) is -26.47%.
| Return on Equity (ROE) | -30.30% |
| Return on Assets (ROA) | -28.20% |
| Return on Capital (ROIC) | -26.47% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.05M |
| Employee Count | 93 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, GPCR has paid $240,000 in taxes.
| Income Tax | 240,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.67% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +12.67% |
| 50-Day Moving Average | 41.90 |
| 200-Day Moving Average | 46.37 |
| Relative Strength Index (RSI) | 39.63 |
| Average Volume (20 Days) | 1,153,480 |
Short Selling Information
| Short Interest | 9.29M |
| Short Previous Month | 7.04M |
| Short % of Shares Out | 16.29% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.94 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -115.14M |
| Pretax Income | -97.44M |
| Net Income | -97.68M |
| EBITDA | -96.01M |
| EBIT | -97.44M |
| Earnings Per Share (EPS) | -$2.28 |
Balance Sheet
The company has $436.45 million in cash and $5.13 million in debt, giving a net cash position of $431.32 million or $7.56 per share.
| Cash & Cash Equivalents | 436.45M |
| Total Debt | 5.13M |
| Net Cash | 431.32M |
| Net Cash Per Share | $7.56 |
| Equity (Book Value) | 429.82M |
| Book Value Per Share | 7.53 |
| Working Capital | 425.77M |
Cash Flow
In the last 12 months, operating cash flow was -$93.26 million and capital expenditures -$2.33 million, giving a free cash flow of -$95.59 million.
| Operating Cash Flow | -93.26M |
| Capital Expenditures | -2.33M |
| Free Cash Flow | -95.59M |
| FCF Per Share | -$2.05 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GPCR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -94.98% |
| Shareholder Yield | -94.98% |
| Earnings Yield | -4.57% |
| FCF Yield | -4.48% |
Analyst Forecast
The average price target for GPCR is $82.17, which is 119.47% higher than the current price. The consensus rating is "Buy".
| Price Target | $82.17 |
| Price Target Difference | 119.47% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -14.40% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |